Different Features
The independent claims of the United States patents differ from each other in the following aspects:
|
Aspects |
US 6255560 (now lapsed) |
||
|---|---|---|---|
|
Promoter Type |
A. tumefaciens opine synthase gene & ribulose−1,5−bis−phosphate carboxylase small subunit (rbcS gene) (Claim 1 & 6) |
a "naturally expressed" in plants (Claim 1 & 8) |
35S CaMV and 19S CaMV (all independent claims) |
|
Antibiotic Resistance Gene |
any (claim 1) & neomycin phosphotransferase (claim 6) |
any (claim 1) & neomycin phosphotransferase (claim 8) |
any |
|
Plant cell comprising a chimeric gene |
not claimed |
not claimed |
The chimeric gene contains one of the CaMV promoters and any antibiotic resistance gene (Claim 3) |
|
An intermediate and a final plant transformation Ti plasmid having a chimeric gene |
not claimed |
not claimed |
The intermediate and final Ti plasmid vectors contain a chimeric gene as mentioned above (Claims 6 & 9) |
|
Particular group of plants having cells containing a chimeric gene differentiated dicotyledonous plants (Claim 12) |
not claimed |
not claimed |
differentiated dicotyledonous plants (Claim 12) |
The information contained in this page was believed to be correct at the time it was collated. New patents and patent applications, altered status of patents, and case law may have resulted in changes in the landscape. CAMBIA makes no warranty that it is correct or up to date at this time and accepts no liability for any use that might be made of it. Corrections or updates to the information are welcome. Please send an email to info@bios.net.
There are no comments.